Page last updated: 2024-08-04 02:08:12

trehalose monomycolate

Description

Cross-References

ID SourceID
PubMed CID134694620
MeSH IDM0075568

Synonyms (2)

Synonym
trehalose monomycolate
C21904

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (10.64)18.7374
1990's4 (8.51)18.2507
2000's10 (21.28)29.6817
2010's20 (42.55)24.3611
2020's8 (17.02)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (6.38%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (93.62%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
carbonyl cyanide m-chlorophenyl hydrazonehydrazone;
monochlorobenzenes;
nitrile
antibacterial agent;
geroprotector;
ionophore
2014201410.0low000010
serineL-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1997199727.0low001000
trehalosetrehaloseEscherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1997202113.7low002122
pyrrolespyrrole;
secondary amine
201420178.5low000020
adamantaneadamantanes;
polycyclic alkane
2012201411.3low000030
ethambutolethanolamines;
ethylenediamine derivative
antitubercular agent;
environmental contaminant;
xenobiotic
1981198143.0low010000
azidespseudohalide anionmitochondrial respiratory-chain inhibitor1997201916.0low001010
glycidyl nitrate201820186.0low000010
trehalose-6-phosphatetrehalose phosphateEscherichia coli metabolite2000200024.0low001000
6,6'-dicorynomycolyl trehalose1993199331.0low001000
arachidonic acidicosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
1995199529.0low001000
oleic acidoctadec-9-enoic acidantioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent
2011201113.0low000010
bm 212201420178.5medium000020
valinomycincyclodepsipeptide;
macrocycle
antimicrobial agent;
antiviral agent;
bacterial metabolite;
potassium ionophore
2014201410.0low000010
sq 109201220237.7low000021
menaquinone 62014201410.0low000010
bedaquilinearomatic ether;
naphthalenes;
organobromine compound;
quinolines;
tertiary alcohol;
tertiary amino compound
antitubercular agent;
ATP synthase inhibitor
202120213.0low000001
acebutololalpha-D-glucosyl-(1->4)-D-mannopyranose202120213.0low000001
corynomycolic acid3-hydroxy fatty acid;
mycolic acid
1991200625.0medium002100
phosphatidylcholines1,2-diacyl-sn-glycero-3-phosphocholine2011201113.0low000010
arabinogalactan201420215.8low000031
glycolipids1981201529.8low050210
piperidines201920195.0low000010
sulfolipid ipolyacyl alpha,alpha-trehalose derivative;
sulfoglycolipid
201520159.0low000010
heme201520159.0low000010
cord factors1981202215.2high0559243
rifampincyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion
angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
202120213.0low000001
araban2014201410.0low000010
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Actinomycetales Infections02011201113.0low000010
Cancer of Lung01995199529.0low001000
Disease Models, Animal02013201311.0low000010
Extensively Drug-Resistant Tuberculosis0201520159.0low000010
Granuloma02005200519.0low000100
Granulomas02005200519.0low000100
Infections, Mycobacterium0201720177.0low000010
Koch's Disease0200520208.3medium000150
Lung Neoplasms01995199529.0low001000
Mycobacterium Infections0201720177.0low000010
Pulmonary Consumption01995200920.7medium001200
Sensitivity and Specificity01995199529.0low001000
Tuberculosis0200520208.3medium000150
Tuberculosis, Drug-Resistant02014201410.0low000010
Tuberculosis, Multidrug-Resistant02014201410.0low000010
Tuberculosis, Pulmonary01995200920.7medium001200